Literature DB >> 11444506

Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies.

E Thorin1.   

Abstract

The normal dilatory response to acetylcholine (ACH) is reduced in coronary vessels from patients with dilated cardiomyopathy (DCM) and reversed to a contraction in patients with coronary artery disease (CAD) and ischemic cardiomyopathy (ICM). This study investigated the influence of nitric oxide synthase inhibition and endothelin (ET)-1 receptor blockade on the reactivity to ACH of coronary arteries isolated from patients with end-stage congestive heart failure (CHF) associated or not with CAD. Small (approximately 400 microm) epicardial right coronary arteries were isolated from explanted hearts of patients undergoing transplantation for DCM or ICM. Segments were mounted on a wire myograph to record changes in isometric tension. ACH (1 microM) dilated pre-contracted vessels from DCM hearts but contracted pre-contracted vessels from ICM hearts. In the absence of pre-contraction, ACH (10(-9)-3 x 10(-5) M) induced a small contraction of rings from DCM hearts and a larger contraction (p < 0.05) of rings from ICM hearts. N(omega)-nitro-L-arginine (L-NNA, 100 microM), a NO synthase inhibitor, increased (p < 0.05) sensitivity and maximal response to ACH of vessels from DCM hearts only. In the presence of L-NNA, blockade of ET(A) with BQ123 (1 microM) prevented the effects of L-NNA in DCM, whereas blockade of ET(A/B) receptors with bosentan (10 microM) only reduced vascular sensitivity to ACH without significantly reducing the maximal contraction to ACH in DCM. The antagonists had no effects in vessels from ICM hearts. ACH, however, induced similar contractions of vessels without endothelium in DCM and ICM. These results suggest that ACH induces a contraction by stimulating smooth muscle muscarinic receptors. In coronary arteries isolated from DCM hearts, the contraction is regulated by NO and ET-1, whereas these factors seem to have little influence in ICM. This suggests that endothelial muscarinic receptors are either not expressed or uncoupled in ICM hearts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444506     DOI: 10.1097/00005344-200107000-00010

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  9 in total

1.  Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X).

Authors:  Peter Ong; Anastasios Athanasiadis; Heiko Mahrholdt; Gabor Borgulya; Udo Sechtem; Juan Carlos Kaski
Journal:  Clin Res Cardiol       Date:  2012-03-10       Impact factor: 5.460

2.  Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion (MINOCA).

Authors:  Giancarlo Pirozzolo; Andreas Seitz; Anastasios Athanasiadis; Raffi Bekeredjian; Udo Sechtem; Peter Ong
Journal:  Clin Res Cardiol       Date:  2019-06-24       Impact factor: 5.460

3.  Role of the M3 muscarinic acetylcholine receptor subtype in murine ophthalmic arteries after endothelial removal.

Authors:  Adrian Gericke; Andreas Steege; Caroline Manicam; Tobias Böhmer; Jürgen Wess; Norbert Pfeiffer
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

Review 4.  Working under pressure: coronary arteries and the endothelin system.

Authors:  Albert Nguyen; Nathalie Thorin-Trescases; Eric Thorin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-03-17       Impact factor: 3.619

Review 5.  Endothelium-derived endothelin-1.

Authors:  Eric Thorin; David J Webb
Journal:  Pflugers Arch       Date:  2009-12-05       Impact factor: 3.657

6.  Activation of ETB receptors regulates the abundance of ET-1 mRNA in vascular endothelial cells.

Authors:  N Farhat; C C Matouk; A M Mamarbachi; P A Marsden; B G Allen; E Thorin
Journal:  Br J Pharmacol       Date:  2008-02-18       Impact factor: 8.739

7.  Accelerated Recovery of Endothelium Function after Stent Implantation with the Use of a Novel Systemic Nanoparticle Curcumin.

Authors:  Qi Lu; Fang Ye; Xiangjun Yang; Qingqing Gu; Peng Wang; Jianhua Zhu; Li Shen; Feirong Gong
Journal:  Biomed Res Int       Date:  2015-06-08       Impact factor: 3.411

8.  Muscarinic Receptor Type-3 in Hypertension and Cholinergic-Adrenergic Crosstalk: Genetic Insights and Potential for New Antihypertensive Targets.

Authors:  Rhéure Alves-Lopes; Karla B Neves; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2019-02-13       Impact factor: 5.223

9.  Anti-CD133 antibody immobilized on the surface of stents enhances endothelialization.

Authors:  Jian Li; Dan Li; Feirong Gong; Shaoyan Jiang; Hua Yu; Yi An
Journal:  Biomed Res Int       Date:  2014-03-10       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.